1. Are nilotinib‐associated vascular adverse events an under‐estimated problem?. (11th March 2015) Authors: Stève‐Dumont, Marie; Baldin, Bernadette; Legros, Laurence; Thyss, Antoine; Re, Daniel; Rocher, Fanny; Ajmia, Florian; Spreux, Anne; Drici, Milou‐Daniel Journal: Fundamental & clinical pharmacology Issue: Volume 29:Number 2(2015) Page Start: 204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. De novo convulsive status epilepticus in patients with multiple sclerosis treated with dalfampridine. (April 2019) Authors: Panicucci, Emilie; Cohen, Mikael; Bourg, Veronique; Rocher, Fanny; Thomas, Pierre; Lebrun, Christine Journal: Multiple sclerosis Issue: Volume 25:Number 4(2019) Page Start: 618 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Immune checkpoint inhibitor–induced bullous pemphigoid: Towards a new class of drug-drug interaction?. (October 2020) Authors: Pujalte-Martin, Marc; Rocher, Fanny; Cardot-Leccia, Nathalie; Giacchero, Damien; Borchiellini, Delphine Journal: European journal of cancer Issue: Volume 138(2020) Page Start: 122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Is TNF inhibitor exposure a risk factor for amyotrophic lateral sclerosis?. (29th May 2019) Authors: Petitpain, Nadine; Devos, David; Bagheri, Haleh; Rocher, Fanny; Gouraud, Aurore; Masmoudi, Kamel; Coquerel, Antoine Journal: Fundamental & clinical pharmacology Issue: Volume 33:Number 6(2019) Page Start: 689 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Poly(ADP‐ribose)polymerase inhibitors‐associated myeloid neoplasms: a retrospective study from the French Network of Pharmacovigilance centres. (5th October 2021) Authors: Morice, Pierre‐Marie; Genthon, Alexis; Boyer, Thomas; Bihan, Kevin; Mahé, Julien; Sourisseau, Anthony; Peyrouzet, Hélène; Miremont, Ghada; Lepelley, Marion; Stefani, Laetitia; Gaboriau, Louise; Rocher, Fanny; Aquaronne, Danièle; Le Beller, Christine; Allouchery, Marion; Azzouz, Brahim; Massy, Nat... Journal: British journal of haematology Issue: Volume 196:Number 3(2022) Page Start: 787 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Remdesivir and Acute Renal Failure: A Potential Safety Signal From Disproportionality Analysis of the WHO Safety Database. Issue 4 (16th January 2021) Authors: Gérard, Alexandre O.; Laurain, Audrey; Fresse, Audrey; Parassol, Nadège; Muzzone, Marine; Rocher, Fanny; Esnault, Vincent L.M.; Drici, Milou‐Daniel Journal: Clinical pharmacology & therapeutics Issue: Volume 109:Issue 4(2021) Page Start: 1021 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Spontaneous adverse event notifications by patients subsequent to the marketing of a new formulation of Levothyrox® amidst a drug media crisis: atypical profile as compared with other drugs. (7th February 2019) Authors: Viard, Delphine; Parassol‐Girard, Nadège; Romani, Serena; Van Obberghen, Elise; Rocher, Fanny; Berriri, Sofia; Drici, Milou‐Daniel Journal: Fundamental & clinical pharmacology Issue: Volume 33:Number 4(2019) Page Start: 463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Spontaneous reported cardiotoxicity induced by lopinavir/ritonavir in COVID-19. An alleged past-resolved problem. (1st February 2021) Authors: Fresse, Audrey; Viard, Delphine; Romani, Serena; Gérard, Alexandre; Lepelley, Marion; Rocher, Fanny; Salem, Joe-Elie; Drici, Milou-Daniel Journal: International journal of cardiology Issue: Volume 324(2021) Page Start: 255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Spontaneous reporting of adverse drug reactions as an outlet for patient dismay? The case of Levothyrox® change of excipients. (18th January 2022) Authors: Romani, Serena; Fresse, Audrey; Parassol‐Girard, Nadège; Gerard, Alexandre; Levraut, Mathieu; Yamani, Samir; Van Obberghen, Elise K.; Pariente, Antoine; Rocher, Fanny; Viard, Delphine; Drici, Milou‐Daniel Journal: Fundamental & clinical pharmacology Issue: Volume 36:Number 3(2022) Page Start: 553 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Therapeutic Drug Monitoring of Direct Oral Anticoagulants May Increase Their Benefit-Risk Ratio. Issue 4 (October 2020) Authors: Bernier, Marjorie; Lancrerot, Sarah Line; Parassol, Nadège; Lavrut, Thibaud; Viotti, Julien; Rocher, Fanny; Drici, Milou-Daniel Journal: Journal of cardiovascular pharmacology Issue: Volume 76:Issue 4(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗